This is a new service – your feedback will help us to improve it.

Technical Advisory Group


The technical advisory group provides guidance on strategic direction and the quality of the Fleming Fund's design. It is made up of these 15 experts in the field of antimicrobial resistance (AMR) from a One Health context.

The Chair of the Technical Advisory Group. Professor of Infectious Disease at Imperial College, a Fellow of the Academy of Medical Sciences and an National Institute for Health Research Senior Investigator.

Professor in Environmental Science in the Environment Department at the University of York. Research focuses on understanding emerging and future ecological and health risks posed by chemical contaminants in the natural environment.

Practices medicine in Kathmandu, Nepal. Research interests are infectious disease and high-altitude medicine. Director for the Oxford University Clinical Research Unit in Nepal and also the Medical Director for the Nepal International Clinic.

Director of the interdisciplinary Antimicrobial Resistance Centre at London School of Hygiene and Tropical Medicine, where she is head of the Anthropology of Antimicrobial Resistance research group.

Dr Didem Torumkuney

Scientific Director for infectious diseases at GSK. Completed her PhD at the Medical Faculty in Istanbul in collaboration with Public Health England on the effect of environmental factors on AMR.

Dr Evelyn Wesangula

Pharmacist heading the Patient Safety Unit at the Ministry of Health in Kenya. She is the National Focal Point on AMR, supporting the implementation of infection prevention and control interventions, surveillance activities, and antibiotic stewardship and awareness programs.

Director of the Oxford University Clinical Research Unit and Wellcome Trust Major Overseas Programme in Vietnam. Research interests focus on the management of severe bacterial infections.

Member of the scientific panel of the Netherlands Veterinary Medicines Institute and is director of the WHO Collaborating Center for Campylobacter and of the OIE-reference laboratory for Campylobacteriosis.

Infectious disease epidemiologist, an Alborada Professor of Equine and Farm Animal Medicine and Head of University of Cambridge Vet School. Co-chairs the University of Cambridge Infectious Diseases Interdisciplinary Research Centre and conducts multidisciplinary research on infectious diseases.

McKinlay Professor of Global Health and Co-Director, Otago Global Health Institute, University of Otago, Dunedin. Also Adjunct Professor of Medicine, Pathology, and Global Health at Duke University and a Guest Researcher with the US Centers for Disease Control and Prevention.

Associate Professor in Health Economics at the London School of Economics and Political Science. Interests include a variety of topics at the intersection of health economics, global health and behavioural economics.

Clinical academic and Reader at the Liverpool School of Tropical Medicine. Consultant in medical microbiology and clinical infectious disease, based at the Malawi Liverpool Wellcome Trust Clinical Research Programme in Blantyre, Malawi.

Principle Pathologist, AMR Lead and Associate Professor at WITS School of Pathology. Currently the deputy chair for GARP and Chair of WHO CC for AMR in South Africa.

Academic clinical microbiologist at the LSHTM and Wellcome Trust Sanger Institute. Works on the implementation of sequencing technologies into routine clinical practice to hospital infections, and characterisation of the genetic relatedness and transmission of pathogenic bacteria in different reservoirs.

Dr Charles Penn

Currently working as an advisor on antimicrobial resistance for the Fleming Fund at the UK Department of Health & Social Care. He has extensive experience in infectious diseases, gained through a PhD in virology from the University of Cambridge, followed by research on human and avian influenza viruses at Cambridge University and the UK Institute for Animal Health.